Chemclin Diagnostics Co., Ltd. (SHA:688468)
6.98
+0.12 (1.75%)
Apr 30, 2025, 2:45 PM CST
Chemclin Diagnostics Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Net Income | - | 147.37 | 152.63 | 142.76 | 117.02 | Upgrade
|
Depreciation & Amortization | - | 48.92 | 51.21 | 52.98 | 42.26 | Upgrade
|
Other Amortization | - | 3.68 | 3.06 | 4.06 | 5.79 | Upgrade
|
Loss (Gain) From Sale of Assets | - | -0.18 | -0.07 | 0.1 | 0.11 | Upgrade
|
Asset Writedown & Restructuring Costs | - | 2.83 | 2.15 | 2.32 | 2.28 | Upgrade
|
Loss (Gain) From Sale of Investments | - | -14.77 | -19.58 | -12.6 | -11.95 | Upgrade
|
Provision & Write-off of Bad Debts | - | -0.41 | 0.02 | 0.14 | 0.29 | Upgrade
|
Other Operating Activities | - | 1.22 | 1.97 | 1.22 | 0.3 | Upgrade
|
Change in Accounts Receivable | - | 3.82 | 6.82 | 22.39 | 25.25 | Upgrade
|
Change in Inventory | - | 1.12 | 7.95 | -25.15 | -14.07 | Upgrade
|
Change in Accounts Payable | - | -11.55 | 26.11 | 4.6 | -19.6 | Upgrade
|
Change in Other Net Operating Assets | - | - | 17.45 | - | 2.98 | Upgrade
|
Operating Cash Flow | - | 173.05 | 244.56 | 188.86 | 151.95 | Upgrade
|
Operating Cash Flow Growth | - | -29.24% | 29.49% | 24.29% | -24.50% | Upgrade
|
Capital Expenditures | - | -301.37 | -125.28 | -72.55 | -83.31 | Upgrade
|
Sale of Property, Plant & Equipment | - | 0.03 | 0.02 | 0.04 | 0.04 | Upgrade
|
Investment in Securities | - | -22 | -10 | -252 | 49 | Upgrade
|
Other Investing Activities | - | 15.66 | 20.76 | 13.97 | 12.06 | Upgrade
|
Investing Cash Flow | - | -307.68 | -114.5 | -310.54 | -22.21 | Upgrade
|
Long-Term Debt Issued | - | 196.48 | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -13.33 | -11.78 | -11.09 | - | Upgrade
|
Net Debt Issued (Repaid) | - | 183.16 | -11.78 | -11.09 | - | Upgrade
|
Issuance of Common Stock | - | - | - | 261.35 | - | Upgrade
|
Common Dividends Paid | - | -139.15 | -68.17 | - | -107.01 | Upgrade
|
Other Financing Activities | - | - | - | -8.26 | -4.18 | Upgrade
|
Financing Cash Flow | - | 44.01 | -79.95 | 242 | -111.19 | Upgrade
|
Foreign Exchange Rate Adjustments | - | 0.08 | 0.4 | -0.1 | -0.3 | Upgrade
|
Net Cash Flow | - | -90.54 | 50.51 | 120.22 | 18.25 | Upgrade
|
Free Cash Flow | - | -128.32 | 119.28 | 116.31 | 68.65 | Upgrade
|
Free Cash Flow Growth | - | - | 2.55% | 69.43% | -52.99% | Upgrade
|
Free Cash Flow Margin | - | -28.81% | 25.64% | 24.71% | 16.41% | Upgrade
|
Free Cash Flow Per Share | - | -0.32 | 0.30 | 0.30 | 0.19 | Upgrade
|
Cash Income Tax Paid | - | 96.57 | 62.9 | 62.44 | 49.93 | Upgrade
|
Levered Free Cash Flow | - | -169.6 | 93.29 | 57.47 | 6.06 | Upgrade
|
Unlevered Free Cash Flow | - | -169.31 | 93.61 | 57.93 | 6.06 | Upgrade
|
Change in Net Working Capital | - | 2.73 | -62.74 | 12.27 | 32.97 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.